Nurix Therapeutics, Inc. NRIX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration revenue | $41.78M-22.6% | $53.98M+0.5% | $53.69M-8.0% | $58.38M+3.5% | $56.42M+3.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nurix Therapeutics, Inc. break its business down?
- Nurix Therapeutics, Inc. (NRIX) reports revenue by product across 2 parts — Collaboration revenue and License revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nurix Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nurix Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
